PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy
Abstract Clinicopathological prognostic features have limited value to identify with precision newly diagnosed patients with hormone receptor (HR)-positive, HER2-negative breast cancer (BC), who would benefit from chemotherapy (CT) in addition to adjuvant hormonal therapy (HT). The 21-gene Oncotype...
Main Authors: | Francesco Cognetti, Riccardo Masetti, Alessandra Fabi, Giulia Bianchi, Donatella Santini, Alessia Rognone, Giovanna Catania, Domenico Angelucci, Giuseppe Naso, Mario Giuliano, Lucia Vassalli, Patrizia Vici, Giovanni Scognamiglio, Daniele Generali, Alberto Zambelli, Marco Colleoni, Corrado Tinterri, Francesco Scanzi, Leonardo Vigna, Paola Scavina, Teresa Gamucci, Emilia Marrazzo, Angelo Fedele Scinto, Rossana Berardi, Maria Agnese Fabbri, Graziella Pinotti, Daniela Franco, Daniela Andreina Terribile, Giuseppe Tonini, Daniela Cianniello, Sandro Barni |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-05-01
|
Series: | npj Breast Cancer |
Online Access: | https://doi.org/10.1038/s41523-021-00246-4 |
Similar Items
-
Patient with metastatic breast cancer, HER2-positive, trastuzumab- and pertuzumab-resistant responding to lapatinib
by: Daniela Cianniello, et al.
Published: (2018-06-01) -
Promoting Emotional Well-Being in Older Breast Cancer Patients: Results From an eHealth Intervention
by: Daniela Villani, et al.
Published: (2018-11-01) -
Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells
by: Giuseppe Vassalli
Published: (2019-01-01) -
Dendritic Cell-Based Approaches for Therapeutic Immune Regulation in Solid-Organ Transplantation
by: Giuseppe Vassalli
Published: (2013-01-01) -
Dalla letteratura alla filosofia. Il Proust di Deleuze
by: Daniela Angelucci
Published: (2019-04-01)